Skip to content

ANIX

Anixa Biosciences Inc (ANIX

NASDAQ · Healthcare · Biotechnology · US

$2.77
+0.36%
Ask drillr
  • Jun 29, 2026, 12:45 UTC

    Anixa Biosciences was granted a Korean patent for its breast cancer vaccine by the Korean Ministry of Intellectual Property, extending protection through 2040.

  • Jun 1, 2026, 13:00 UTC

    Anixa Biosciences received a Notice of Allowance from the Canadian Intellectual Property Office for a patent covering its ovarian cancer vaccine technology.